Korro Bio (KRRO) News Today $47.56 -2.14 (-4.31%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Korro Bio, Inc. (NASDAQ:KRRO) Receives Consensus Rating of "Buy" from AnalystsKorro Bio, Inc. (NASDAQ:KRRO - Get Free Report) has been given an average rating of "Buy" by the six ratings firms that are covering the company, Marketbeat.com reports. Five analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company.November 15 at 2:55 AM | marketbeat.comKorro to Present at the Jefferies London Healthcare ConferenceNovember 14 at 8:00 AM | globenewswire.comKorro Bio’s Promising KRRO-110 Developments and Strong Financial Position Justify Buy RatingNovember 14 at 3:12 AM | markets.businessinsider.comKorro Bio’s Progress and Financial UpdatesNovember 14 at 12:03 AM | tipranks.comKorro Bio (NASDAQ:KRRO) Earns "Outperform" Rating from William BlairWilliam Blair reissued an "outperform" rating on shares of Korro Bio in a research report on Wednesday.November 13, 2024 | marketbeat.comKorro Bio, Inc. (NASDAQ:KRRO) CFO Vineet Agarwal Sells 800 SharesNovember 13, 2024 | insidertrades.comKorro Bio (NASDAQ:KRRO) Stock Price Up 10.9% - Here's What HappenedKorro Bio (NASDAQ:KRRO) Trading 10.9% Higher - Here's What HappenedNovember 7, 2024 | marketbeat.comKorro Bio’s Promising Regulatory and Preclinical Advances Earn a Buy Rating from Analyst Mitchell KapoorNovember 6, 2024 | markets.businessinsider.comKorro Bio (KRRO) Gets a Buy from Piper SandlerNovember 4, 2024 | markets.businessinsider.comKorro Bio announces regulatory filing for initiation of KRRO-110November 4, 2024 | markets.businessinsider.comKorro Bio (NASDAQ:KRRO) Shares Gap Down - Should You Sell?Korro Bio (NASDAQ:KRRO) Shares Gap Down - Here's What HappenedNovember 4, 2024 | marketbeat.comKorro Announces Regulatory Filing for Initiation of KRRO-110 First-In-Human Study and Formation of Clinical Advisory BoardNovember 4, 2024 | globenewswire.comKorro Bio (NASDAQ:KRRO) Trading Down 5.1% - Time to Sell?Korro Bio (NASDAQ:KRRO) Trading Down 5.1% - Should You Sell?October 28, 2024 | marketbeat.comKorro Bio (NASDAQ:KRRO) Sees Unusually-High Trading Volume - What's Next?Korro Bio (NASDAQ:KRRO) Sees Strong Trading Volume - Should You Buy?October 23, 2024 | marketbeat.comKorro Bio initiated with a Strong Buy at Raymond JamesOctober 22, 2024 | markets.businessinsider.comRaymond James Initiates Coverage of Korro Bio (KRRO) with Strong Buy RecommendationOctober 22, 2024 | msn.comKorro Bio price target raised to $105 from $95 at RBC CapitalOctober 22, 2024 | markets.businessinsider.comKorro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space.October 21, 2024 | investors.comRoyal Bank of Canada Boosts Korro Bio (NASDAQ:KRRO) Price Target to $105.00Royal Bank of Canada boosted their target price on Korro Bio from $95.00 to $105.00 and gave the company an "outperform" rating in a research report on Monday.October 21, 2024 | marketbeat.comKorro Bio, Inc. (NASDAQ:KRRO) Given Consensus Recommendation of "Buy" by BrokeragesShares of Korro Bio, Inc. (NASDAQ:KRRO - Get Free Report) have been given an average recommendation of "Buy" by the five analysts that are presently covering the stock, MarketBeat reports. Five equities research analysts have rated the stock with a buy rating. The average twelve-month price targetOctober 21, 2024 | marketbeat.comKorro Bio (NASDAQ:KRRO) Coverage Initiated at Raymond JamesRaymond James initiated coverage on shares of Korro Bio in a research note on Monday. They set a "strong-buy" rating and a $153.00 price objective for the company.October 21, 2024 | marketbeat.comInsider Selling: Korro Bio, Inc. (NASDAQ:KRRO) CFO Sells 10,216 Shares of StockKorro Bio, Inc. (NASDAQ:KRRO - Get Free Report) CFO Vineet Agarwal sold 10,216 shares of the stock in a transaction on Thursday, October 17th. The stock was sold at an average price of $78.26, for a total value of $799,504.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.October 18, 2024 | marketbeat.comKorro Bio (NASDAQ:KRRO) Trading Down 4.1% - Should You Sell?Korro Bio (NASDAQ:KRRO) Trading Down 4.1% - Time to Sell?October 18, 2024 | marketbeat.comPromising RNA Editing Developments and KRRO-110 Potential Drive Buy Rating for Korro BioOctober 18, 2024 | markets.businessinsider.comHC Wainwright Increases Korro Bio (NASDAQ:KRRO) Price Target to $115.00HC Wainwright lifted their price objective on shares of Korro Bio from $100.00 to $115.00 and gave the stock a "buy" rating in a report on Friday.October 18, 2024 | marketbeat.comKorro Bio (NASDAQ:KRRO) Stock, Insider Trading ActivityOctober 17, 2024 | benzinga.comKorro Bio (NASDAQ:KRRO) Sees Large Volume Increase - Here's WhyKorro Bio (NASDAQ:KRRO) Sees Strong Trading Volume - Still a Buy?October 17, 2024 | marketbeat.comKorro Bio (NASDAQ:KRRO) Shares Gap Up - Here's WhyKorro Bio (NASDAQ:KRRO) Shares Gap Up - Here's WhyOctober 16, 2024 | marketbeat.comMillennium Management LLC Grows Stock Holdings in Korro Bio, Inc. (NASDAQ:KRRO)Millennium Management LLC grew its holdings in shares of Korro Bio, Inc. (NASDAQ:KRRO - Free Report) by 38.3% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 84,201 shares of the company's stock after purchasing an additional 23,307 shares during the period.October 15, 2024 | marketbeat.comKorro Bio, Inc. (NASDAQ:KRRO) Short Interest UpdateKorro Bio, Inc. (NASDAQ:KRRO - Get Free Report) saw a significant decrease in short interest in the month of September. As of September 30th, there was short interest totalling 222,800 shares, a decrease of 11.9% from the September 15th total of 253,000 shares. Based on an average daily trading volume, of 66,100 shares, the days-to-cover ratio is presently 3.4 days. Currently, 3.8% of the company's shares are short sold.October 15, 2024 | marketbeat.comKorro Announces Oral and Poster Presentations at the 20th Annual Meeting of the Oligonucleotide Therapeutics SocietySeptember 30, 2024 | globenewswire.comPoint72 Asset Management L.P. Purchases 190,259 Shares of Korro Bio, Inc. (NASDAQ:KRRO)Point72 Asset Management L.P. boosted its position in shares of Korro Bio, Inc. (NASDAQ:KRRO - Free Report) by 71.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 456,085 shares of the company's stSeptember 30, 2024 | marketbeat.comKorro Bio (NASDAQ:KRRO) Stock, Short Interest ReportSeptember 28, 2024 | benzinga.comKorro Bio, Inc. (NASDAQ:KRRO) Position Increased by NEA Management Company LLCNEA Management Company LLC raised its position in Korro Bio, Inc. (NASDAQ:KRRO - Free Report) by 1.7% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,090,793 shares of the company's stock after acquiring an additionSeptember 25, 2024 | marketbeat.com19,148 Shares in Korro Bio, Inc. (NASDAQ:KRRO) Purchased by Bank of New York Mellon CorpBank of New York Mellon Corp acquired a new stake in Korro Bio, Inc. (NASDAQ:KRRO - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 19,148 shares of the company's stock, valued at apSeptember 24, 2024 | marketbeat.com71,428 Shares in Korro Bio, Inc. (NASDAQ:KRRO) Acquired by Tri Locum Partners LPTri Locum Partners LP acquired a new position in shares of Korro Bio, Inc. (NASDAQ:KRRO - Free Report) in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 71,428 shares of the company's stock, valued at approximately $2,419,000. Korro BiSeptember 23, 2024 | marketbeat.com3 Stocks That Could Rise on European Bank Interest Rate Cuts (KRRO)The European Central Bank cut interest rates for the second time in about three months prior the FOMC's interest rate announcement, European stocks may benefit.September 22, 2024 | marketbeat.comRBC Capital Reaffirms Their Buy Rating on Korro Bio (KRRO)September 19, 2024 | markets.businessinsider.comKorro Bio (NASDAQ:KRRO) Stock Quotes, Forecast and News SummarySeptember 19, 2024 | benzinga.comAnalysts Offer Predictions for Korro Bio, Inc.'s Q3 2024 Earnings (NASDAQ:KRRO)Korro Bio, Inc. (NASDAQ:KRRO - Free Report) - Stock analysts at William Blair issued their Q3 2024 earnings per share estimates for Korro Bio in a report issued on Monday, September 16th. William Blair analyst M. Minter expects that the company will post earnings of ($2.79) per share for the quarSeptember 19, 2024 | marketbeat.comKorro Bio’s Strategic Partnership and RNA Editing Innovation Prompts Buy RatingSeptember 18, 2024 | markets.businessinsider.comBuy Rating Affirmed: Korro Bio’s Strategic Partnership with Novo Nordisk and Promising RNA Editing PlatformSeptember 18, 2024 | markets.businessinsider.comKorro Bio's (KRRO) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright reissued a "buy" rating and set a $100.00 price target on shares of Korro Bio in a research report on Tuesday.September 17, 2024 | marketbeat.comAtlas Venture Life Science Advisors LLC Has $38.52 Million Stock Position in Korro Bio, Inc. (NASDAQ:KRRO)Atlas Venture Life Science Advisors LLC lifted its position in Korro Bio, Inc. (NASDAQ:KRRO - Free Report) by 1.6% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 1,137,149 shares of the company's stock after purchasing an additional 17,857 shSeptember 15, 2024 | marketbeat.comWill Korro Bio (NASDAQ:KRRO) Spend Its Cash Wisely?September 4, 2024 | finance.yahoo.comKorro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of DirectorsAugust 28, 2024 | markets.businessinsider.comKorro to Participate in Upcoming September Investor and Scientific ConferencesAugust 27, 2024 | globenewswire.comKorro Bio stock poised for growth with upcoming clinical validation - Piper SandlerAugust 16, 2024 | uk.investing.comKorro Bio, Inc. Expected to Earn FY2024 Earnings of ($11.15) Per Share (NASDAQ:KRRO)Korro Bio, Inc. (NASDAQ:KRRO - Free Report) - Equities researchers at William Blair issued their FY2024 EPS estimates for Korro Bio in a research report issued on Wednesday, August 14th. William Blair analyst M. Minter forecasts that the company will post earnings of ($11.15) per share for the yeAugust 16, 2024 | marketbeat.comGene Editing Korro Bio's Preclinical Data 'Best-In-Class', Analyst Initiates With Outperform RatingAugust 15, 2024 | msn.com Get Korro Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for KRRO and its competitors with MarketBeat's FREE daily newsletter. Email Address The only candlestick pattern worth a darn (Ad)It’s widely known that 80% of daily market action is driven by Wall Street algorithms… Now, most people think of the algorithms are “bad” When in reality, they are neither good nor bad… They are simply programmed to buy and sell certain stocks over and over again… But here is the thing… They are predictable… They typically buy the same stocks at the same levels over and over again… Follow this link here and enter your email address to sign up… KRRO Media Mentions By Week KRRO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KRRO News Sentiment▼0.720.56▲Average Medical News Sentiment KRRO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KRRO Articles This Week▼112▲KRRO Articles Average Week Get Korro Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for KRRO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Longboard Pharmaceuticals News Amphastar Pharmaceuticals News Akero Therapeutics News NewAmsterdam Pharma News Scholar Rock News Recursion Pharmaceuticals News Mirum Pharmaceuticals News Harmony Biosciences News Wave Life Sciences News Centessa Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KRRO) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Korro Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Korro Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KRRO Stock Alerts